DENVER (June 7, 2018) – PRESS RELEASE – Dr. Michele Ross, neuroscientist, author and cannabinoid medicine leader, has joined the advisory board for NanoSphere Health Sciences, LLC, the biotechnology company behind the patented NanoSphere Delivery System, which nano-encapsulates cannabinoid molecules in lipid membranes for transportation through the skin into the bloodstream within minutes. The company currently offers its pioneering product—Transdermal NanoSerum—under the brand Evolve Formulas, with plans to release intranasal and intraoral products in the coming months.
Dr. Ross brings to the NanoSphere board a wealth of industry knowledge, advocacy experience and insight into particular patient needs. Her work as founder and executive director of IMPACT Network, a non-profit which focuses on cannabis and women’s health, and as CEO of Infused Health, a digital platform which provides educational resources to cannabis patients, has helped consumers around the world and trained the next generation of cannabis healthcare professionals. Dr. Ross entered the cannabis industry as both a scientist and cannabis patient, having been diagnosed with fibromyalgia, neuropathy and chronic pelvic pain.
In her new role, Dr. Ross will take part in product development and strategy meetings, offer expertise on Evolve Formulas products and co-author scientific papers with NanoSphere’s chief science officer, Dr. Richard Kaufman. Dr. Ross will also partake in ambassadorship activities for Evolve Formulas and NanoSphere technology, beginning with a speaking engagement on behalf of the company at the O’Cannabiz Conference and Expo in Toronto this weekend, June 9, covering cannabis and women’s issues.
“NanoSphere Health Sciences prides itself on bringing together the best scientific minds to create breakthrough advancements for patients. Dr. Ross becoming a member of our board, and an ambassador of our technology, widens this circle of innovation and excellence while also bringing to the table a unique insight into patient experience. We look forward to working with Dr. Ross to improve our offerings and form mutually beneficial partnerships,” said Robert Sutton, chairman and CEO of NanoSphere Health Sciences and Evolve Formulas.
“I continuously look for the best cannabis products to meet patients’ needs. The NanoSphere Delivery System and the Evolve Formulas products bring a new technology to the market that provides one-of-a-kind benefits to those suffering from pain, inflammation, anxiety, distress, seizures and beyond. I am proud to be contributing to the development of NanoSphere’s offerings and to further their mission of making cannabis delivery safer and more effective,” Said Dr. Michele Ross, Member of the Board of Advisors for NanoSphere Health Sciences.
Photo courtesy of NanoSphere Health Sciences